Send in the Clones
Send in the Clones
Will a relaxed attitude to regulation make Singapore the stem-cell-research capital of the world?
New breed of VCs banking on biotech
New breed of VCs banking on biotech
As the era of rock-star venture capitalists investing in Internet start-ups appears to be ending, another era is dawning — one of VCs flocking into biotech and health care.
Biology Seeks a Few Good Geeks
Biology Seeks a Few Good Geeks
The declaration is perhaps not as stirring as Uncle Sam calling patriotic men into the army in World War I, but Vicky Markstein is just as determined in her pursuit and convinced of its importance to the nation and the welfare of humanity.
Biotechs on edge as money evaporates
Biotechs on edge as money evaporates
Seattle’s biotech industry is working on some of the most complicated medical science in the world, but it relies on a simple mantra its executives know by heart: “Cash is king.”
Making a Run for the Border-For Canadian Prescription Drugs
Making a Run for the Border-For Canadian Prescription Drugs
Picture a tour bus filled with American seniors heading for a visit north of the border, to Canada. Instead of paying a visit to the Canadian side of Niagara Falls, they are off to purchase Canadian prescription drugs. As strange as this sight may seem, this is part of one of the latest trends in pharmaceutical marketing: online cross-border pharmacies.
Get updates by email
Editor
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.
and Share
Reading
Translator
© Copyright - BiotechBlog — A thinkBiotech product
Recent Comments